相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。[89Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models
Yun Lu et al.
MOLECULES (2021)
Imaging Phenotypes of Breast Cancer Heterogeneity in Preoperative Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) Scans Predict 10-Year Recurrence
Rhea D. Chitalia et al.
CLINICAL CANCER RESEARCH (2020)
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
Rachael M. Zemek et al.
FRONTIERS IN IMMUNOLOGY (2020)
Multiparametric Analysis of Longitudinal Quantitative MRI Data to Identify Distinct Tumor Habitats in Preclinical Models of Breast Cancer
Anum K. Syed et al.
CANCERS (2020)
Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2+breast cancer
Angela M. Jarrett et al.
SCIENTIFIC REPORTS (2020)
MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer
Almir G. Bitencourt et al.
EBIOMEDICINE (2020)
CANCER Physical traits of cancer
Hadi T. Nia et al.
SCIENCE (2020)
Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+breast cancer
Angela M. Jarrett et al.
MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2019)
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
John D. Martin et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors
Chengyue Wu et al.
MAGNETIC RESONANCE IN MEDICINE (2019)
Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+Breast Cancer
Anum K. Syed et al.
NEOPLASIA (2019)
Repeatability, Reproducibility, and Accuracy of Quantitative MRI of the Breast in the Community Radiology Setting
Anna G. Sorace et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)
Intratumor heterogeneity defines treatment-resistant HER2+breast tumors
Inga H. Rye et al.
MOLECULAR ONCOLOGY (2018)
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis
John Virostko et al.
JOURNAL OF MEDICAL IMAGING (2018)
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
Shih-ying Huang et al.
NPJ BREAST CANCER (2018)
Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+Breast Cancer
Anna G. Sorace et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
A Novel Unsupervised Segmentation Approach Quantifies Tumor Tissue Populations Using Multiparametric MRI: First Results with Histological Validation
Prateek Katiyar et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
DCE- and DW-MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancer
Stephanie L. Barnes et al.
NMR IN BIOMEDICINE (2017)
Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways
Jia Wu et al.
CLINICAL CANCER RESEARCH (2017)
Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+breast cancer: preliminary results
Anna G. Sorace et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Quantitative Imaging in Cancer Clinical Trials
Thomas E. Yankeelov et al.
CLINICAL CANCER RESEARCH (2016)
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
John D. Martin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Clinical management of breast cancer heterogeneity
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer
Hee Jin Lee et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Quantitative multimodality imaging in cancer research and therapy
Thomas E. Yankeelov et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts
Devin R. McCormack et al.
BIOMEDICAL OPTICS EXPRESS (2014)
Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients
Matthew D. Onsum et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Basal/HER2 breast carcinomas Integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)
Begona Martin-Castillo et al.
CELL CYCLE (2013)
Magnetic resonance of calcified tissues
Felix W. Wehrli
JOURNAL OF MAGNETIC RESONANCE (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
A quantitative comparison of the influence of individual versus population-derived vascular input functions on dynamic contrast enhanced-MRI in small animals
Mary E. Loveless et al.
MAGNETIC RESONANCE IN MEDICINE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
A. Fangberget et al.
EUROPEAN RADIOLOGY (2011)
99mTc-(CO)3 His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab
Christel Vangestel et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: Rat cerebral glioma blood volume determination
Xin Li et al.
JOURNAL OF MAGNETIC RESONANCE (2010)
Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu(+) tumors
Matthew E. Hardee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Her2-positive breast cancer: Herceptin and beyond
Windy Dean-Colomb et al.
EUROPEAN JOURNAL OF CANCER (2008)
Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples
Thomas E. Yankeelov et al.
CURRENT MEDICAL IMAGING REVIEWS (2007)
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
AU Buzdar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Variation of the relaxographic shutter-speed for transcytolemmal water exchange affects the CR bolus-tracking curve shape
TE Yankeelov et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
分享论文
